3 minor leaguers given suspensions for positive drug tests

NEW YORK -- St. Louis Cardinals right-hander Kener Perez, San Diego Padres left-hander Ibrahym Jimenez and free agent left-hander Yonathan Frias were suspended for 56 games each Friday following positive tests for performance-enhancing drugs.

Perez tested positive for Stanozolol, Jimenez for Nandrolone and Frias for Boldenone, the commissioner's office said Friday. All three were penalized under the drug program for minor league players assigned outside of the United States and Canada.

Perez, 19, was 1-4 with an 8.31 ERA in seven relief appearances this year in his second season with the Dominican Summer League Cardinals. He signed a minor league contract in February 2023 for a $10,000 bonus.

Jimenez, 17, signed this past January for a $10,000 bonus and was 1-1 with a 3.60 ERA in four starts and three relief appearances with the DSL Gold Padres.

Frias, 18, was released by the DLS Braves on Tuesday with a 4.26 ERA in six relief appearances. He signed in January 2023 for a $35,000 bonus and had an 8.31 ERA last year in 14 relief appearances for the DLS Braves.

Thirteen baseball players have been suspended this year for positive drug tests, including five under the new program for minor league players assigned outside the United States and Canada and six under the minor league program.

Two players have been suspended this year under the major league drug program.

Noelvi Marte, a 22-year-old infielder who is the Cincinnati Reds' top prospect, missed the first 80 games of the season following a positive test for Boldenone.

Toronto Blue Jays infielder Orelvis Martinez was suspended for 80 games on June 23 following a positive test for the performance-enhancing drug Clomiphene, an announcement made two days after his major league debut.